Cargando…
Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A‐related cancer stem cell biology
The C‐type lectin domain family 12, member A (CLEC12A) receptor has emerged as a leukaemia‐associated and cancer stem cell marker in myeloid malignancies. However, a detailed delineation of its expression in normal haematopoiesis is lacking. Here, we have characterized the expression pattern of CLEC...
Autores principales: | Bill, Marie, B. van Kooten Niekerk, Peter, S. Woll, Petter, Laine Herborg, Laura, Stidsholt Roug, Anne, Hokland, Peter, Nederby, Line |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867061/ https://www.ncbi.nlm.nih.gov/pubmed/29411522 http://dx.doi.org/10.1111/jcmm.13519 |
Ejemplares similares
-
Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome
por: Toft‐Petersen, Marie, et al.
Publicado: (2016) -
A novel del(8)(q23.2q24.11) contributing to disease progression in a case of JAK2/TET2 double mutated chronic myelomonocytic leukemia
por: Toft-Petersen, Marie, et al.
Publicado: (2014) -
CLEC2 and CLEC5A: Pathogenic Host Factors in Acute Viral Infections
por: Sung, Pei-Shan, et al.
Publicado: (2019) -
Expression of the myeloid inhibitory receptor CLEC12A correlates with disease activity and cytokines in early rheumatoid arthritis
por: Vaillancourt, Myriam, et al.
Publicado: (2021) -
CLEC12A Binds to Legionella pneumophila but Has No Impact on the Host’s Antibacterial Response
por: Klatt, Ann-Brit, et al.
Publicado: (2023)